Clobazam
NDC 62135-527, Clobazam, suspension, from Chartwell RX, LLC.
- Product NDC
- 62135-527
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213110
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/62135-527 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLOBAZAM2.5 mg/mL
Pharmacologic classes
Benzodiazepine [EPC]; Benzodiazepines [CS]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-527-41 | 62135052741 | 120 mL in 1 BOTTLE (62135-527-41) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/17c3b9db-9e25-4a17-ac45-bcd17ea0360cNADAC price for package 62135052741
GET /v1/drugs/nadac/62135052741
Use it
Look up 62135-527 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-527 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-527. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.